Covered recipient · General Payments record
ALYSSA FINCK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,133.66
- Reported across 153 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $529.74 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $273.11 | 19 |
| Lilly USA, LLC | $81.25 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.80 | 4 |
| Amgen Inc. | $55.64 | 4 |
| Vanda Pharmaceuticals Inc. | $19.44 | 1 |
| PFIZER INC. | $15.08 | 1 |
| Neurocrine BioSciences, Inc. | $14.22 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.52 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729067 | CMS |
| ABBVIE INC. | $12.53 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729069 | CMS |
| ABBVIE INC. | $15.03 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729071 | CMS |
| ABBVIE INC. | $11.50 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729073 | CMS |
| ABBVIE INC. | $16.51 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729075 | CMS |
| ABBVIE INC. | $21.15 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729077 | CMS |
| ABBVIE INC. | $18.56 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729079 | CMS |
| ABBVIE INC. | $14.30 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729081 | CMS |
| ABBVIE INC. | $14.63 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729083 | CMS |
| ABBVIE INC. | $15.57 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729085 | CMS |
| ABBVIE INC. | $7.01 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729087 | CMS |
| ABBVIE INC. | $14.97 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729089 | CMS |
| ABBVIE INC. | $14.54 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729091 | CMS |
| ABBVIE INC. | $14.20 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729093 | CMS |
| ABBVIE INC. | $10.65 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729095 | CMS |
| ABBVIE INC. | $23.46 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729097 | CMS |
| ABBVIE INC. | $9.62 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729099 | CMS |
| ABBVIE INC. | $17.03 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729101 | CMS |
| ABBVIE INC. | $8.33 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103729103 | CMS |
| Amgen Inc. | $13.66 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111574840 | CMS |
| Amgen Inc. | $14.43 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111574842 | CMS |
| Amgen Inc. | $14.43 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111574844 | CMS |
| Amgen Inc. | $13.12 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111574846 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.20 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117863947 | CMS |
| Lilly USA, LLC | $18.75 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136028807 | CMS |
| Lilly USA, LLC | $13.84 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136030235 | CMS |
| Lilly USA, LLC | $18.29 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136027676 | CMS |
| Lilly USA, LLC | $14.87 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136020428 | CMS |
| Lilly USA, LLC | $15.50 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136028809 | CMS |
| Neurocrine Biosciences, Inc. | $14.22 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150877092 | CMS |
| Novartis Pharmaceuticals Corporation | $15.01 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086915063 | CMS |
| Novartis Pharmaceuticals Corporation | $13.93 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086915069 | CMS |
| Novartis Pharmaceuticals Corporation | $15.38 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086915071 | CMS |
| Novartis Pharmaceuticals Corporation | $13.48 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086915073 | CMS |
| PFIZER INC. | $15.08 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131562599 | CMS |
| Vanda Pharmaceuticals Inc. | $19.44 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133902439 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.